![]() |
市場調查報告書
商品編碼
2026920
皮膚填充劑市場預測至2034年—按產品、藥物類型、材料、分銷管道、應用、最終用戶和地區分類的全球分析Dermal Fillers Market Forecasts to 2034 - Global Analysis By Product (Biodegradable, Non-Biodegradable and Other Products), Drug Type, Material, Distribution Channel, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球皮膚填充劑市場規模將達到 72.8 億美元,在預測期內以 9.8% 的複合年成長率成長,到 2034 年將達到 153.8 億美元。
皮膚填充劑是一種微創治療方法,使用凝膠狀材料。它們用於改善臉部皮膚外觀,透過注射給藥。這些治療方法可以減少皺紋,使臉部看起來更年輕。它們還有助於減少痤瘡疤痕,並用於改善唇部和臉部皺紋。
根據世界衛生組織的估計,到2034年,全球六分之一的人口將達到或超過60歲。統計數據顯示,老年人口預計將從2020年的10億增加到2050年的21億,翻倍。
微創手術的廣泛應用
微創手術是治療方法。它主要針對臉部細紋和皺紋等問題,透過減少多餘脂肪和體積來改善臉部輪廓。全球對微創能量型皮膚緊緻、除皺、臉部塑形和活膚療程的需求顯著。因此,微創手術日益普及預計將推動市場成長。
皮膚填充劑的副作用
用於製造永久性皮膚填充劑的成分無法被人體消化吸收。因此,人體可能會啟動自身防禦反應,從而導致感染疾病和生物膜形成等後果。此外,永久性填充劑會對人體造成不可逆的損傷,且無法移除。公眾對皮膚填充劑副作用日益成長的擔憂,可能會在一定程度上限制市場成長。
新型皮膚填充劑的進展
皮膚填充劑是一種凝膠狀化合物,注射到皮膚下後,可以減少細紋、撫平皺紋並補充流失的容量。由於無需手術或恢復期,它們是保持年輕容顏的有效治療選擇。這些填充劑注射到皮膚下,有助於豐盈臉部皺紋。雖然這類填充劑種類繁多,但最常見的是玻尿酸和氫氧化鈣磷灰石。皮膚填充劑品牌的改進將有助於提升市場需求。
美容手術高成本
費用是選擇美容項目時需要考慮的因素之一。皮膚填充劑的費用取決於填充劑的種類和用量。此外,注射醫生的訓練和經驗也會影響費用。皮膚填充劑是一種流行的美容項目,可以恢復流失的容量並改善各種老化跡象。雖然這是一種安全的門診手術,但高昂的費用預計會限制市場需求。
新冠疫情對美容皮膚科和醫療產業造成了嚴重衝擊,導致全球生產困難和供應鏈中斷。封鎖措施、旅行限制和勞動力短缺共同造成了皮膚填充劑生產、分銷和運輸的延誤,導致許多地區供應短缺,難以獲得。此外,在疫情高峰期,包括美容治療在內的非必要醫療程序受到嚴格限制,導致非必要診所暫時關閉,美容服務需求急劇下降。
在預測期內,可生物分解材料細分市場預計將成為最大的細分市場。
在預測期內,可生物分解填充劑預計將成為最大的市場佔有率。這類填充劑旨在實現溫和、自然的豐盈效果,同時模擬臉部特徵。它們可用於改善唇部和臉頰等臉部特徵,填充皺紋和細紋,並增加臉部容量。與永久性填充劑不同,可生物分解的皮膚填充劑旨在隨著時間的推移逐漸分解並被人體吸收。這使得患者可以根據自身不斷變化的需求和偏好調整容貌。
在預測期內,透明質酸細分市場預計將呈現最高的複合年成長率。
在預測期內,玻尿酸細分市場預計將呈現最高的複合年成長率。深層皺紋、細紋、皮膚鬆弛和容量流失只是玻尿酸皮膚填充劑可以改善的幾個例子。它們還可用於改善疤痕和其他皮膚缺陷的外觀,以及突出嘴唇和顴骨。由於有多種配方可供選擇,醫生可以根據每位患者的特定需求量身定做治療方案。
預計北美將在預測期內佔據最大的市場佔有率。這主要歸功於其在男性群體中日益成長的受歡迎程度、該地區「永葆青春」潮流的興起以及對非手術美容項目需求的不斷成長。該地區的人們往往非常注重自身對美和外表的理想標準。因此,人們對皮膚填充劑的需求日益成長,將其作為改善臉部特徵和減少老化徵兆的手段。
預計亞太地區在預測期內將維持最高的複合年成長率。隨著可支配收入的增加,該地區越來越多的人將有能力負擔美容手術。此外,作為熱門的醫療旅遊目的地,許多人前往該地區接受美容治療,該地區的美容行業正在快速發展。同時,該地區的審美標準也在發生變化,豐唇、高顴骨等特徵變得越來越重要。
According to Stratistics MRC, the Global Dermal Fillers Market is accounted for $7.28 billion in 2026 and is expected to reach $15.38 billion by 2034 growing at a CAGR of 9.8% during the forecast period. Dermal fillers are less invasive treatments that employ gel-based materials. These are utilized to enhance the appearance of the facial skin and come in the form of injectables. These treatments contribute to a more youthful appearance by minimizing wrinkles. These procedures are helpful in reducing acne scars and are utilized to improve lips and facial wrinkles.
According to WHO estimates, by 2034, one in every six people in the world will be 60 or older. As per statistics, the geriatric population size will get double from 1 billion in 2020 to 2.1 billion in 2050.
Rising prevalence of minimally-invasive procedures
A treatment known as minimally-invasive surgery is one that is carried out with the use of specialized surgical tools and a scope for seeing. It reduces extra fat, volume, and contour while focusing on face abnormalities including fine lines and wrinkles. There is a great demand worldwide for minimally invasive energy-based skin tightening, wrinkle reduction, face sculpting, and skin rejuvenation procedures. Thus, the increasing prevalence of minimally invasive procedures is expected to drive growth in the market.
Side effects associated with dermal fillers
The ingredients used to make permanent dermal fillers are indigestible to the human body. As a result, the body will probably defend itself, which might result in consequences including infections and the development of biofilms. Furthermore, permanent fillers harm the human body irreversibly and are not removed. A rising number of people's concerns about the negative consequences of using dermal fillers may limit the market's evolution to some extent.
Advancement in the new dermal fillers
Dermal fillers are compounds that resemble gel and are injected beneath the skin to smooth lines, soften wrinkles, and replenish lost volume. Without requiring surgery or downtime, these fillers are a useful therapeutic option for looking younger. This medication is injected beneath the skin to help plump up wrinkles on the face. This medications come in a variety of forms; the most popular ones are hyaluronic acid and calcium hydroxylapatite, among others. Improvements in dermal filler brands will contribute to increased market demand.
High cost of aesthetic procedures
Cost is a factor that is taken into account for elective procedures. Dermal filler costs vary based on the kind and quantity utilized in the procedure. The cost of the procedure also depends on the training and experience of the practitioner applying dermal fillers. Dermal filler is a popular cosmetic operation that may restore lost volume and cure various indications of aging. It is a safe outpatient procedure, but the expensive cost of the treatments is anticipated to limit market demand.
The COVID-19 pandemic had a detrimental influence on the cosmetic dermatology and aesthetic medicine industries, which suffered production issues and supply chain interruptions internationally. Lockdown procedures, travel restrictions, and a smaller labor force all contributed to delays in dermal filler manufacture, distribution, and transit, which in turn resulted in shortages and restricted availability in different areas. Furthermore, at the pandemic's height, there were severe restrictions on elective medical procedures, including beauty treatments. This led to the temporary closure of non-essential clinics and a sharp drop in the demand for cosmetic services.
The biodegradable segment is expected to be the largest during the forecast period
The biodegradable segment is expected to be the largest during the forecast period. They are intended to create a mild, natural-looking augmentation while imitating the facial features. They can be used to improve facial features like the lips and cheeks, fill in wrinkles and fine lines, and add volume to the face. Biodegradable dermal fillers, in contrast to permanent fillers, are intended to progressively degrade and be absorbed by the body over time. This implies that patients can modify their look to suit their changing demands and tastes.
The hyaluronic acid segment is expected to have the highest CAGR during the forecast period
The hyaluronic acid segment is expected to have the highest CAGR during the forecast period. Deep creases, wrinkles, fine lines, and volume loss are just a few of the issues that can be resolved with hyaluronic acid dermal fillers. They may also be used to improve the look of scars and other skin defects, as well as to accentuate the lips and cheekbones. Because they come in various formulations, practitioners may tailor therapies to the specific requirements of each patient.
North America is projected to hold the largest market share during the forecast period. This is due to males are becoming more popular, there is a growing trend of ageless beauty in the area, and there is an increased need for non-surgical cosmetic operations. The region's populace is very conscious of ideals of beauty and physical attractiveness. Because of this, dermal fillers are in high demand as a way to improve face characteristics and lessen aging symptoms.
Asia Pacific is projected to hold the highest CAGR over the forecast period. More people in the area may afford cosmetic operations as disposable income rises. Due to the region's popularity as a medical tourism destination, many individuals come here for cosmetic procedures-the area industry has grown rapidly. In addition, the region's ideals of beauty are evolving, placing an increasing focus on characteristics like big lips and high cheekbones.
Key players in the market
Some of the key players in Dermal Fillers market include Allergan , Anika Therapeutics, Inc., BIOXIS Pharmaceuticals, Elan aesthetics Inc, FillMed Laboratories, Galderma Laboratories, L.P., Merz Pharma, Prollenium Medical Technologies, Teoxane Laboratories, Revance Therapeutics, Inc., Sinclair Pharma, Suneva Medical, Vital Esthetique Laboratories, Contura International ltd., Zimmer Aesthetic and BioPlus Co., Ltd.
In April 2023, Sinclair Pharma announced that it has received European CE mark for Perfectha Lidocaine, a hyaluronic acid dermal filler pre-mixed with lidocaine. This will make the filler more comfortable for patients to receive.
In March 2023, Revance Therapeutics announced that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for TAO, a hyaluronic acid dermal filler for the correction of moderate to severe facial wrinkles and folds.
In February 2023, Galderma received FDA approval for Restylane Defyne, a hyaluronic acid dermal filler for chin augmentation. This is the first FDA-approved dermal filler specifically for chin augmentation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.